Unresolved disorder model. using A ATOM 176 CA ASER 22 -16.036 -10.650 -33.808 0.70 20.22 C Unresolved disorder model. using A ATOM 177 CA BSER 22 -16.080 -10.656 -33.809 0.30 19.40 C Unresolved disorder model. using A ATOM 180 CB ASER 22 -16.891 -11.740 -34.444 0.70 20.29 C Unresolved disorder model. using A ATOM 181 CB BSER 22 -17.041 -11.686 -34.394 0.30 19.26 C Unresolved disorder model. using A ATOM 182 OG ASER 22 -18.238 -11.348 -34.494 0.70 23.12 O Unresolved disorder model. using A ATOM 183 OG BSER 22 -16.666 -12.003 -35.719 0.30 17.40 O Unresolved disorder model. using A ATOM 308 CA AMET 38 -10.564 6.884 -35.638 0.70 18.93 C Unresolved disorder model. using A ATOM 309 CA BMET 38 -10.567 6.892 -35.640 0.30 19.05 C Unresolved disorder model. using A ATOM 312 CB AMET 38 -10.800 8.392 -35.528 0.70 18.47 C Unresolved disorder model. using A ATOM 313 CB BMET 38 -10.829 8.400 -35.529 0.30 18.89 C Unresolved disorder model. using A ATOM 314 CG AMET 38 -12.244 8.793 -35.562 0.70 20.53 C Unresolved disorder model. using A ATOM 315 CG BMET 38 -12.289 8.802 -35.600 0.30 20.22 C Unresolved disorder model. using A ATOM 316 SD AMET 38 -12.468 10.537 -35.915 0.70 25.26 S Unresolved disorder model. using A ATOM 317 SD BMET 38 -12.498 10.556 -35.925 0.30 23.05 S Unresolved disorder model. using A ATOM 318 CE AMET 38 -14.259 10.627 -36.102 0.70 14.71 C Unresolved disorder model. using A ATOM 319 CE BMET 38 -11.673 10.708 -37.514 0.30 19.01 C Unresolved disorder model. using A ATOM 698 CA AMET 89 -24.364 14.587 -33.339 0.70 23.77 C Unresolved disorder model. using A ATOM 699 CA BMET 89 -24.336 14.602 -33.353 0.30 23.57 C Unresolved disorder model. using A ATOM 702 CB AMET 89 -23.560 15.858 -33.098 0.70 23.72 C Unresolved disorder model. using A ATOM 703 CB BMET 89 -23.473 15.854 -33.173 0.30 23.67 C Unresolved disorder model. using A ATOM 704 CG AMET 89 -22.380 15.994 -34.018 0.70 26.07 C Unresolved disorder model. using A ATOM 705 CG BMET 89 -22.249 15.902 -34.084 0.30 24.63 C Unresolved disorder model. using A ATOM 706 SD AMET 89 -21.390 17.368 -33.440 0.70 32.73 S Unresolved disorder model. using A ATOM 707 SD BMET 89 -21.202 17.308 -33.693 0.30 28.43 S Unresolved disorder model. using A ATOM 708 CE AMET 89 -20.116 17.280 -34.683 0.70 26.89 C Unresolved disorder model. using A ATOM 709 CE BMET 89 -22.287 18.651 -34.186 0.30 23.53 C Unresolved disorder model. using A ATOM 1114 CA ATRP 141 -14.104 16.768 -30.577 0.50 18.80 C Unresolved disorder model. using A ATOM 1115 CA BTRP 141 -14.106 16.770 -30.566 0.50 18.86 C Unresolved disorder model. using A ATOM 1118 CB ATRP 141 -14.800 18.012 -31.140 0.50 19.08 C Unresolved disorder model. using A ATOM 1119 CB BTRP 141 -14.824 17.988 -31.149 0.50 19.21 C Unresolved disorder model. using A ATOM 1120 CG ATRP 141 -15.619 17.815 -32.410 0.50 21.03 C Unresolved disorder model. using A ATOM 1121 CG BTRP 141 -15.394 17.698 -32.501 0.50 21.24 C Unresolved disorder model. using A ATOM 1122 CD1ATRP 141 -16.795 18.443 -32.710 0.50 24.32 C Unresolved disorder model. using A ATOM 1123 CD1BTRP 141 -15.024 16.697 -33.337 0.50 24.26 C Unresolved disorder model. using A ATOM 1124 CD2ATRP 141 -15.309 16.996 -33.548 0.50 24.41 C Unresolved disorder model. using A ATOM 1125 CD2BTRP 141 -16.406 18.444 -33.190 0.50 26.59 C Unresolved disorder model. using A ATOM 1126 NE1ATRP 141 -17.241 18.054 -33.945 0.50 24.27 N Unresolved disorder model. using A ATOM 1127 NE1BTRP 141 -15.744 16.757 -34.501 0.50 25.93 N Unresolved disorder model. using A ATOM 1128 CE2ATRP 141 -16.350 17.169 -34.484 0.50 25.00 C Unresolved disorder model. using A ATOM 1129 CE2BTRP 141 -16.610 17.815 -34.434 0.50 25.84 C Unresolved disorder model. using A ATOM 1130 CE3ATRP 141 -14.267 16.123 -33.862 0.50 26.30 C Unresolved disorder model. using A ATOM 1131 CE3BTRP 141 -17.155 19.580 -32.876 0.50 27.08 C Unresolved disorder model. using A ATOM 1132 CZ2ATRP 141 -16.379 16.495 -35.713 0.50 27.66 C Unresolved disorder model. using A ATOM 1133 CZ2BTRP 141 -17.532 18.287 -35.373 0.50 29.36 C Unresolved disorder model. using A ATOM 1134 CZ3ATRP 141 -14.297 15.463 -35.086 0.50 27.67 C Unresolved disorder model. using A ATOM 1135 CZ3BTRP 141 -18.092 20.036 -33.805 0.50 30.11 C Unresolved disorder model. using A ATOM 1136 CH2ATRP 141 -15.347 15.645 -35.988 0.50 28.50 C Unresolved disorder model. using A ATOM 1137 CH2BTRP 141 -18.266 19.394 -35.036 0.50 29.75 C Unresolved disorder model. using A ATOM 2322 CA AGLN 293 -7.516 -8.984 0.777 0.50 29.37 C Unresolved disorder model. using A ATOM 2323 CA BGLN 293 -7.529 -9.022 0.800 0.50 29.20 C Unresolved disorder model. using A ATOM 2326 CB AGLN 293 -8.914 -9.332 1.309 0.50 29.77 C Unresolved disorder model. using A ATOM 2327 CB BGLN 293 -8.876 -9.493 1.356 0.50 29.51 C Unresolved disorder model. using A ATOM 2328 CG AGLN 293 -10.103 -8.904 0.398 0.50 30.34 C Unresolved disorder model. using A ATOM 2329 CG BGLN 293 -8.895 -10.918 1.903 0.50 29.18 C Unresolved disorder model. using A ATOM 2330 CD AGLN 293 -10.050 -7.437 -0.073 0.50 30.72 C Unresolved disorder model. using A ATOM 2331 CD BGLN 293 -10.306 -11.477 2.027 0.50 31.34 C Unresolved disorder model. using A ATOM 2332 OE1AGLN 293 -10.402 -7.131 -1.209 0.50 32.29 O Unresolved disorder model. using A ATOM 2333 OE1BGLN 293 -10.854 -11.531 3.120 0.50 33.08 O Unresolved disorder model. using A ATOM 2334 NE2AGLN 293 -9.608 -6.542 0.793 0.50 31.37 N Unresolved disorder model. using A ATOM 2335 NE2BGLN 293 -10.900 -11.878 0.911 0.50 30.54 N Unresolved disorder model. using A ATOM 2404 CA AMET 303 9.707 -27.180 -9.467 0.50 20.49 C Unresolved disorder model. using A ATOM 2405 CA BMET 303 9.708 -27.188 -9.480 0.50 20.75 C Unresolved disorder model. using A ATOM 2408 CB AMET 303 9.244 -28.379 -10.260 0.50 20.73 C Unresolved disorder model. using A ATOM 2409 CB BMET 303 9.248 -28.429 -10.248 0.50 21.24 C Unresolved disorder model. using A ATOM 2410 CG AMET 303 9.145 -28.075 -11.716 0.50 22.30 C Unresolved disorder model. using A ATOM 2411 CG BMET 303 8.859 -28.185 -11.694 0.50 23.81 C Unresolved disorder model. using A ATOM 2412 SD AMET 303 8.651 -29.513 -12.604 0.50 25.39 S Unresolved disorder model. using A ATOM 2413 SD BMET 303 10.218 -28.245 -12.876 0.50 29.60 S Unresolved disorder model. using A ATOM 2414 CE AMET 303 9.004 -28.934 -14.243 0.50 24.72 C Unresolved disorder model. using A ATOM 2415 CE BMET 303 9.289 -28.842 -14.278 0.50 29.03 C Unresolved disorder model. using A ATOM 3166 CA ASER 399 -20.847 -34.076 -12.020 0.50 28.92 C Unresolved disorder model. using A ATOM 3167 CA BSER 399 -20.847 -34.076 -12.029 0.50 28.96 C Unresolved disorder model. using A ATOM 3170 CB ASER 399 -21.823 -35.119 -11.442 0.50 29.22 C Unresolved disorder model. using A ATOM 3171 CB BSER 399 -21.812 -35.134 -11.471 0.50 29.26 C Unresolved disorder model. using A ATOM 3172 OG ASER 399 -23.057 -35.089 -12.133 0.50 27.64 O Unresolved disorder model. using A ATOM 3173 OG BSER 399 -21.104 -36.252 -10.970 0.50 28.02 O Unresolved disorder model. using A ATOM 3332 CA ALEU 419 -9.568 -20.111 -19.443 0.50 20.99 C Unresolved disorder model. using A ATOM 3333 CA BLEU 419 -9.554 -20.162 -19.475 0.50 20.90 C Unresolved disorder model. using A ATOM 3336 CB ALEU 419 -9.480 -19.006 -18.382 0.50 21.16 C Unresolved disorder model. using A ATOM 3337 CB BLEU 419 -9.327 -19.114 -18.396 0.50 21.02 C Unresolved disorder model. using A ATOM 3338 CG ALEU 419 -8.446 -17.880 -18.579 0.50 22.52 C Unresolved disorder model. using A ATOM 3339 CG BLEU 419 -8.082 -18.250 -18.626 0.50 21.88 C Unresolved disorder model. using A ATOM 3340 CD1ALEU 419 -8.494 -16.854 -17.445 0.50 21.55 C Unresolved disorder model. using A ATOM 3341 CD1BLEU 419 -8.448 -16.988 -19.423 0.50 20.26 C Unresolved disorder model. using A ATOM 3342 CD2ALEU 419 -7.050 -18.456 -18.690 0.50 21.74 C Unresolved disorder model. using A ATOM 3343 CD2BLEU 419 -7.450 -17.901 -17.288 0.50 21.46 C Chain identifier should be blank not A: ATOM 3449 MG MG A 428 -10.378 8.782 -30.260 1.00 17.43 A MG Chain identifier should be blank not B: ATOM 3506 MG MG B 429 -0.163 -20.388 -19.457 1.00 17.66 B MG 1